sur More Impact AG (ETR:AEE1)
US Patent Notice for More Impact AG's Innovation
More Impact AG, headquartered in Frankfurt, recently announced a significant development. Their subsidiary, BG Braingate Technology, received a Notice of Allowance from the US Patent and Trademark Office (USPTO). This notice pertains to a cutting-edge device and method for the extraction of biological components, focusing particularly on cannabinoids like CBD.
This patent recognition advances their international commercial prospects. It signifies a crucial step for marketing products developed using their patented extraction technology. These products can be administered through medical inhalers or needleless syringes based on medical needs.
Dr. Karsten Behlke, BG Braingate's Managing Director, emphasized the patent's strategic importance for international protection and commercial ventures in plant-based substances. More Impact AG's CEO, Dr. Gerald Schüssel, highlighted the patent's role in demonstrating their portfolio's technological innovations on a global stage.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de More Impact AG